Cell–cell interactions were constrained using an automated model selection method together with previous observations and new in vivo data from a chimeric BCR-ABL1 transgenic mouse model of CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.